Z16.30
Resistance to unspecified antimicrobial drugs
Clinical Classification Guidelines
Inclusion Terms
- Drug resistance NOS
Medical Intelligence & Overview
ICD-10 Code Z16.30 refers to resistance to unspecified antimicrobial drugs. This condition indicates that bacteria or other microorganisms are resistant to medications used to treat infections, making these infections more difficult to treat. Resistance develops when microorganisms change in ways that reduce or eliminate the effectiveness of drugs designed to cure or prevent infections, posing significant challenges to healthcare management. This code is used when the specific antimicrobial resistance is not specified or detailed.
Causes & Symptoms
Clinical Causes: Inappropriate use of antibiotics or antimicrobial agents, such as taking them without prescription or not completing prescribed courses. Overuse of antibiotics in agriculture and farming, leading to resistant strains in the environment. Repeated exposure to antibiotics, which allows microbes to adapt and develop resistance. Transmission of resistant bacteria from person to person or through contaminated food and water sources. Lack of infection control measures in healthcare settings, facilitating the spread of resistant strains.
Key Symptoms: Persistent infections that do not respond to standard antibiotic treatments Recurrent infections with the same pathogen despite therapy Prolonged illness duration Increased severity of symptoms in some cases Complications arising from ineffective treatment
Diagnostic & Treatment
Diagnosis Path: Culture and sensitivity testing to assess microbial growth and drug susceptibility Molecular methods, such as PCR, to detect resistance genes Monitoring clinical response to treatment to identify potential resistance Reviewing patient history for prior antimicrobial use and exposure
Treatment Protocols: Using alternative or combination antibiotic therapies based on susceptibility results Implementing infection control practices to prevent spread Optimizing antimicrobial stewardship programs to promote the appropriate use of antibiotics Supporting research and development of new antimicrobial agents Educating patients and healthcare providers about responsible antimicrobial use
Clinical Advice & FAQs
Billing Guidance
Is Z16.30 a billable ICD-10 code?
Yes, Z16.30 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z16.30?
Clinical documentation must specify the nature of Resistance to unspecified antimicrobial drugs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference